21 results
10-Q
2021 Q2
RNAZ
TransCode Therapeutics Inc
23 Aug 21
Quarterly report
4:53pm
, which could expose us to criminal sanctions, civil penalties, exclusion from government healthcare programs, contractual damages, reputational harm … , contractual damages, reputational harm and diminished profits and future earnings.
Although we do not currently have any drugs on the market, if we begin
10-K
2021 FY
RNAZ
TransCode Therapeutics Inc
31 Mar 22
Annual report
11:19am
us to criminal sanctions, civil penalties, exclusion from government healthcare programs, contractual damages, reputational harm and diminished … penalties, damages, fines, imprisonment, disgorgement, exclusion from government funded healthcare programs, such as Medicare and Medicaid, reputational
DRS
RNAZ
TransCode Therapeutics Inc
29 Jul 22
Draft registration statement
12:00am
and regulations, which could expose us to criminal sanctions, civil penalties, exclusion from government healthcare programs, contractual damages, reputational … of trade privileges, debarment, tax reassessments, breach of contract and fraud litigation, reputational harm, and other consequences. We have direct
DRS/A
jcy9nxls71xl 1tvr
27 Jan 21
Draft registration statement (amended)
12:00am
DRS
rikicm4l8x4fa 3dz8yt
18 Dec 20
Draft registration statement
12:00am
424B4
bmq 6nv3we838z0zyc1
19 Jan 24
Prospectus supplement with pricing info
9:57pm
424B4
ts13j7
9 Jul 21
Prospectus supplement with pricing info
5:22pm